Gyros AB has appointed Dan Calvo president and CEO, replacing Erik Wallden.
Calvo was most recently president and CEO of Oncimmune USA. He was previously president and CEO of Assay Designs and Cellomics.
Sid Taubenfeld has joined Arrayit's board of directors.
Taubenfeld has served as an analyst for a number of Wall Street hedge funds, including Balyasny Asset Management, RH Capital, and PAW Partners. Additionally, Taubenfeld served as director of communications and strategic initiatives for Celsion Corp.
CyVek has appointed Bill Dubiel chief commercial officer.
Dubiel joins CyVek from Roche Tissue Diagnostics where he was vice president of sales. Before that he held senior positions at Bayer Healthcare, Chiron, and Ciba-Corning Diagnostics.